ERBB2 and breast cancer: Vega-Rubín-de-CelisS et al. [11] have explored the regulated mechanism of HER2 to autophagy in vita, and the impacts of genetic and pharmacological strategies on HER2-driven BC proliferation enhancing autophagy in vivo.